Partnering to Invest in TB

Supporting sustainable domestic investment in the fight against TB

TB remains the world’s deadliest infectious disease, and yet efforts to bring it under control are considerably underfunded. TB needs double the current annual contributions to meet the commitments outlined within the 2018 UN Political Declaration. 

Given this, and the scale of the global TB burden, this makes TB one of the best investments governments and other stakeholders can make: alongside lives saved, one estimate puts a return on investment at $43 for every $1 spent on care in high TB-burden countries.

The coronavirus pandemic has put all health systems around the world under unprecedented levels of strain, which have severely negatively impacted the number of people being both diagnosed and treated for TB. However, in the longer term, it is possible that the sizable investments being made in the C-19 response could be of benefit to TB patients. This is because they require similar approaches in terms of the infrastructure required to track, trace, and screen patients.  

In its latest paper, the Stop TB PSC lays out how multisectoral partnerships can support increased domestic financing, and in particular how private sector organizations have a key role to play in providing the expertise, innovation, practical support, and technical guidance needed to sustain TB programs.

As a private sector working group, our purpose is to help advance the battle against TB in the ways each of our members know best. We work directly with multi-sectoral stakeholders -- governments, NGO’s, and other innovators -- to elevate TB on global and national political agendas, and explore new engagement models to spread awareness and mobilize funds.